Pharmaceutical

Ionis' inhaled antisense medicine demonstrates potential as a novel treatment for cystic fibrosis

13 days ago   |   By San Diego Biotechnology

Data from the first clinical study of IONIS-ENAC-2.5 Rx to be presented at North American Cystic Fibrosis Conference
CARLSBAD, Calif., Oct. 13, 2020 /PRNewswire/ - Ionis Pharmaceuticals, Inc. , the leader in antisense therapeutics, a......
Read more ...

 


Search by Tags

   Pharmaceutical      Therapeutics      Clinical      Medicine      Pharmaceuticals      News      PR Newswire      Syndication      Biotechnology      Clinical Trials      Medical Discoveries      Health Care      Hospitals      Medical      Tradeshow News  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Egyptian Genome Added to Growing List of Population-Specific Reference Genomes

Egyptian Genome Added to Growing List of Population-Specific Reference Genomes

We're excited to report that another team has used PacBio long-read sequencing to produce a population-specific reference genome - this time an Egyptian genome that should... Read more ...

DURECT Corporation to Participate in the ROTH Capital Partners Healthcare...

CUPERTINO, Calif., Oct. 26, 2020 /PRNewswire/ - DURECT Corporation today announced that it will partipate in the ROTH Capital Healthcare Event, "Covid-19 Therapeutics in... Read more ...

Section 230: A Reform Agenda for the Next Administration

Section 230 has been the subject of bipartisan criticism in Washington, with both President Trump and former Vice President Biden arguing that the controversial law should be... Read more ...

Scientists develop genetic 'monitors' that detect when genes are active

Genetic sensors that can detect the activity from genes, rather than just the genes themselves, have been developed by a team led by University of Warwick scientists. Read more ...

Wrinkled 'super pea' could be added to foods to reduce diabetes risk

A type of wrinkled 'super pea' may help control blood sugar levels and could reduce the risk of type 2 diabetes, suggests a new study. Read more ...

SDBN Podcast: How Does a New Biotech Company Successfully Launch Its First...

After many years with a focus on R&D, how does a biotech company then launch its first product with no track record in the market and no established relationships while... Read more ...

Correction to: Deep user identification model with multiple biometric data

An amendment to this paper has been published and can be accessed via the original article. Read more ...

Literature based discovery of alternative TCM medicine for adverse reactions...

In recent years, Traditional Chinese Medicine and alternative medicine have been widely used along with western drugs as a complementary form of treatment. In this study, we... Read more ...

Literature mining for context-specific molecular relations using multimodal...

Biological contextual information helps understand various phenomena occurring in the biological systems consisting of complex molecular relations. The construction of... Read more ...

2-D chemical structure image-based in silico model to predict agonist...

Abnormal activation of human nuclear hormone receptors disrupts endocrine systems and thereby affects human health. There have been machine learning-based models to predict... Read more ...